Billionaire Bill Ackman Predicts $1 Trillion Israeli Company Within 5 Years

American billionaire investor Bill Ackman, founder of Pershing Square, expressed optimism about Israel's economic future, predicting that a company valued at $1 trillion will emerge from the country within five to ten years. Speaking at the Sheba Medical Center's ARC Summit, Ackman cited Israel's high ratio of IQ and intellectual property relative to its population size as a key driver for AI-driven growth.

Ackman, who is married to an Israeli woman, stated that Israeli entrepreneurs are increasingly focused on building large companies rather than early sales, a shift he believes will lead to this significant economic milestone. He also revealed that he and his wife invested 5% in the Tel Aviv Stock Exchange after the October 7th attacks, as a message of confidence in the Israeli economy.

Discussing the impact of artificial intelligence on healthcare, Ackman suggested that consumers and patients will be the primary beneficiaries, leading to unprecedented accessibility in health services and education. He shared a personal anecdote about using an AI model, which he calls "Doctor Claude," to consult on the care of his daughter, who suffered a severe brain hemorrhage. Ackman believes it will soon be irresponsible for patients or doctors not to consult leading AI models for proposed treatments.

Furthermore, Ackman is establishing a new institute focused on neuroscience and rehabilitation, inspired by his daughter's recovery. The institute aims to drastically shorten the time lag between scientific discovery and patient treatment, which he noted can currently be as long as 17 years in the field of rehabilitation.

Ackman also commented on the regional situation, suggesting that prospects for peace have dramatically improved and risk has significantly decreased, anticipating further expansion of the Abraham Accords regardless of Israel's leadership. He expressed general optimism about technological advancements, foreseeing an era of immense prosperity driven by AI, brain-computer interfaces, and medical technologies.